Leukemia, T-Cell
Information
- Disease name
- Leukemia, T-Cell
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00001249 | Completed | Phase 1 | Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac | December 1989 | October 2000 |
| NCT00001533 | Completed | Phase 1 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | September 1996 | September 2000 |
| NCT00095381 | Completed | Phase 2 | Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia | March 2004 | December 2007 |
| NCT06345027 | Not yet recruiting | Phase 1 | CHIMERIC ANTIGEN RECEPTOR TREATMENT TARGETING CD70 (SEVENTY) | April 1, 2024 | April 1, 2042 |
| NCT05619861 | Recruiting | N/A | CAR-T Cells in the Treatment of Malignant Hematological Tumors | April 27, 2020 | December 26, 2023 |
| NCT02518750 | Terminated | Phase 2 | Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma | November 23, 2016 | March 11, 2018 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015458